BlueCard PPO
Sarah McElhaney, LMFT
Des Moines, IA
Accepting new patients
Clinical Overview
Sarah McElhaney, LMFT works in Des Moines, IA as
Insurance & Payment Information
* Please verify this information when scheduling an appointment.
-
-
HealthyBlue Advantage
-
Cigna PPOLocalPlusOpen Access Plus
-
Blue PPOAlliance Select
-
Premier Care Network Plus - Innovation HealthElect Choice (Open Access) EPOOpen Choice PPOManaged Choice (Open Access) POSChoice Plus POS IIAPCN Choice POS IIAetna HMO
-
First Health (Coventry Health Care) PPO
Office Locations
-
Children and Families of Iowa1111 University Ave, Des Moines, IA 50314
-
Julie McClatchey LISW PC5000 Westown Pkwy Ste 100, West Des Moines, IA 50266
Medical Expertise & Background
Specialties*
Marriage & Family Therapy
- *Medical News Today does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Common Patient Questions
Sarah McElhaney, LMFT accepts new patients on Medical News Today.
Sarah McElhaney accepts Blue Cross Blue Shield, CareFirst BlueCross BlueShield, Cigna, Wellmark Blue Cross and Blue Shield, Aetna and First Health as well as many others. See all of the insurances Sarah McElhaney accepts here.
Sarah McElhaney's office is located at 1111 University Ave Des Moines, IA 50314. Get a map and directions to Sarah McElhaney's office here.
Sarah McElhaney does not have any reviews yet.
Claim Your Profile
Are you Sarah McElhaney, LMFT?
Know Before You Go
Preventive care: what doctors want you to know
Preventive care can help identify current or future health and medical concerns before they become major.
Featured Stories
A study found that people who used estrogen-only menopausal hormonal therapy were less likely to show increased Alzheimer’s disease pathology, and lower chances of memory decline and a dementia diagnosis.
On August 10, 2026, President Donald Trump signed an executive order recommending separate measles, mumps and rubella vaccinations. Medical experts explain why this recommendation is controversial.
New preclinical research has made a key discovery regarding the spread of ovarian cancer after chemotherapy. Fructose may play a role, it found.
